Sino Biopharmaceutical (OTCMKTS:SBMFF) Trading Down 8.5% – Time to Sell?

Sino Biopharmaceutical (OTCMKTS:SBMFF) traded down 8.5% during mid-day trading on Monday . The company traded as low as $0.6959 and last traded at $0.6959. 604 shares were traded during mid-day trading, a decline of 55% from the average session volume of 1,350 shares. The stock had previously closed at $0.7602.

Sino Biopharmaceutical Stock Down 8.5%

The stock’s fifty day simple moving average is $0.79 and its 200-day simple moving average is $0.84.

About Sino Biopharmaceutical

Sino Biopharmaceutical Limited (OTCMKTS: SBMFF) is a Hong Kong–incorporated investment holding company principally engaged in the pharmaceutical sector. Founded in 2000 and listed on the Hong Kong Stock Exchange in 2006, the company has developed an integrated business model that spans research and development, manufacturing and commercialization of healthcare products. Through its subsidiaries, Sino Biopharmaceutical focuses on enhancing China’s domestic pharmaceutical infrastructure while expanding its footprint across key therapeutic areas.

The company’s product portfolio is organized into three core segments: infusion solutions, small-molecule synthetic pharmaceuticals and innovative biologics.